Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

radionuclide therapy

  • Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
    Open Access
    Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
    Lisa M. Gudenkauf, Melody N. Chavez, Melinda Leigh Maconi, Carley Geiss, Ameen Seyedroudbari, Pan Thin, Aasha I. Hoogland, Kathleen Nguyen, Vishnu Murthy, Wesley R. Armstrong, Khaled Komrokji, Laura B. Oswald, Heather S.L. Jim, Ghassan El-Haddad, Wolfgang P. Fendler, Ken Herrmann, David Cella, Johannes Czernin, Michael S. Hofman, Adam P. Dicker, Jeremie Calais, Scott T. Tagawa and Brian D. Gonzalez
    Journal of Nuclear Medicine May 4, 2023, jnumed.122.264946; DOI: https://doi.org/10.2967/jnumed.122.264946
  • <sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
    You have access
    64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
    Dale L. Bailey, Kathy P. Willowson, Matthew Harris, Colin Biggin, Alireza Aslani, Nigel A. Lengkeek, Jon Stoner, M. Enid Eslick, Harry Marquis, Michelle Parker, Paul J. Roach and Geoffrey P. Schembri
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 704-710; DOI: https://doi.org/10.2967/jnumed.122.264586
  • Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
    You have access
    Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
    Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, Cleo Goyvaerts, Kim De Veirman, Alfred Morgenstern, Frank Bruchertseifer, Marleen Keyaerts, Nick Devoogdt, Matthias D’Huyvetter and Karine Breckpot
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 751-758; DOI: https://doi.org/10.2967/jnumed.122.264752
  • Open Access
    Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
    Mark S. Longtine, Kyuhwan Shim, Mark J. Hoegger, Nadia Benabdallah, Diane S. Abou, Daniel L.J. Thorek and Richard L. Wahl
    Journal of Nuclear Medicine April 20, 2023, jnumed.122.265167; DOI: https://doi.org/10.2967/jnumed.122.265167
  • You have access
    Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
    Shadi A. Esfahani, Carolina De Aguiar Ferreira, Priska Summer, Umar Mahmood and Pedram Heidari
    Journal of Nuclear Medicine April 6, 2023, jnumed.123.265391; DOI: https://doi.org/10.2967/jnumed.123.265391
  • Open Access
    An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose
    Julia Brosch-Lenz, Suqi Ke, Hao Wang, Eric Frey, Yuni K. Dewaraja, John Sunderland and Carlos Uribe
    Journal of Nuclear Medicine April 6, 2023, jnumed.122.265094; DOI: https://doi.org/10.2967/jnumed.122.265094
  • You have access
    PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
    Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R. Benz, Ida Sonni, Irene A. Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang P. Fendler, Manuel M. Weber, Michael S. Hofman, Thomas A. Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine March 30, 2023, jnumed.122.265242; DOI: https://doi.org/10.2967/jnumed.122.265242
  • Open Access
    PSMA-GCK01 - A Generator-Based 99mTc-/188Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
    Jens Cardinale, Frederik L. Giesel, Christina Wensky, Hendrik G. Rathke, Uwe Haberkorn and Clemens Kratochwil
    Journal of Nuclear Medicine February 9, 2023, jnumed.122.264944; DOI: https://doi.org/10.2967/jnumed.122.264944
  • You have access
    161Tb-PSMA Radioligand Therapy: First-in-human SPECT/CT Imaging
    Akram Al-Ibraheem, Rahma M. Doudeen, Diyaa Juaidi, Alaa Abufara and Stephan Maus
    Journal of Nuclear Medicine February 9, 2023, jnumed.122.265291; DOI: https://doi.org/10.2967/jnumed.122.265291
  • You have access
    Radioimmunoscintigraphy and pre-treatment dosimetry of 131I-omburtamab for planning treatment of leptomeningeal disease
    Neeta Pandit-Taskar, Milan Grkovski, Pat B. Zanzonico, Keith S. Pentlow, Shakeel Modak, Kim Kramer and John L. Humm
    Journal of Nuclear Medicine February 9, 2023, jnumed.122.265131; DOI: https://doi.org/10.2967/jnumed.122.265131

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire